OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Liver Fibrosis: A Compilation on the Biomarkers Status and Their Significance During Disease Progression
Krishna Sumanth Nallagangula, Shashidhar Kurpad Nagaraj, V Lakshmaiah, et al.
Future Science OA (2017) Vol. 4, Iss. 1
Open Access | Times Cited: 145
Krishna Sumanth Nallagangula, Shashidhar Kurpad Nagaraj, V Lakshmaiah, et al.
Future Science OA (2017) Vol. 4, Iss. 1
Open Access | Times Cited: 145
Showing 1-25 of 145 citing articles:
Role of inflammatory response in liver diseases: Therapeutic strategies
J.A. Del Campo, Paloma Gallego, Lourdes Grande
World Journal of Hepatology (2018) Vol. 10, Iss. 1, pp. 1-7
Open Access | Times Cited: 302
J.A. Del Campo, Paloma Gallego, Lourdes Grande
World Journal of Hepatology (2018) Vol. 10, Iss. 1, pp. 1-7
Open Access | Times Cited: 302
Biosensors as diagnostic tools in clinical applications
Catarina Lino, Sara Barrias, Raquel Chaves, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 3, pp. 188726-188726
Open Access | Times Cited: 61
Catarina Lino, Sara Barrias, Raquel Chaves, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 3, pp. 188726-188726
Open Access | Times Cited: 61
Integrins as a drug target in liver fibrosis
S. Rahman, James A. Roper, Jane I. Grove, et al.
Liver International (2022) Vol. 42, Iss. 3, pp. 507-521
Open Access | Times Cited: 51
S. Rahman, James A. Roper, Jane I. Grove, et al.
Liver International (2022) Vol. 42, Iss. 3, pp. 507-521
Open Access | Times Cited: 51
Interleukin-10 induces senescence of activated hepatic stellate cells via STAT3-p53 pathway to attenuate liver fibrosis
Yuehong Huang, Minghua Chen, Qilan Guo, et al.
Cellular Signalling (2019) Vol. 66, pp. 109445-109445
Open Access | Times Cited: 67
Yuehong Huang, Minghua Chen, Qilan Guo, et al.
Cellular Signalling (2019) Vol. 66, pp. 109445-109445
Open Access | Times Cited: 67
Autophagy inhibition attenuates the induction of anti-inflammatory effect of catalpol in liver fibrosis
Zhaoguo Liu, Pingting Zhu, Lin Zhang, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 103, pp. 1262-1271
Closed Access | Times Cited: 64
Zhaoguo Liu, Pingting Zhu, Lin Zhang, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 103, pp. 1262-1271
Closed Access | Times Cited: 64
Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD
Vanda Marques, Marta B. Afonso, Nina Bierig, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 53
Vanda Marques, Marta B. Afonso, Nina Bierig, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 53
Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis
Anshika Jangra, Ashish Kothari, Phulen Sarma, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1500-1500
Open Access | Times Cited: 33
Anshika Jangra, Ashish Kothari, Phulen Sarma, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1500-1500
Open Access | Times Cited: 33
Reprogramming activated hepatic stellate cells by siRNA-loaded nanocarriers reverses liver fibrosis in mice
Mahmoud A. Younis, Yusuke Sato, Yaser Hosny Ali Elewa, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 592-603
Open Access | Times Cited: 20
Mahmoud A. Younis, Yusuke Sato, Yaser Hosny Ali Elewa, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 592-603
Open Access | Times Cited: 20
Serum biomarkers of fibrosis and extracellular matrix remodeling in patients with nonalcoholic fatty liver disease: association with liver histology
Yusuf Yılmaz, Fatih Eren
European Journal of Gastroenterology & Hepatology (2018) Vol. 31, Iss. 1, pp. 43-46
Closed Access | Times Cited: 52
Yusuf Yılmaz, Fatih Eren
European Journal of Gastroenterology & Hepatology (2018) Vol. 31, Iss. 1, pp. 43-46
Closed Access | Times Cited: 52
Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment
Hyo Jung Cho, Bohyun Kim, Hye Jin Kim, et al.
European Radiology (2020) Vol. 30, Iss. 8, pp. 4182-4192
Closed Access | Times Cited: 47
Hyo Jung Cho, Bohyun Kim, Hye Jin Kim, et al.
European Radiology (2020) Vol. 30, Iss. 8, pp. 4182-4192
Closed Access | Times Cited: 47
S-Acetyl-Glutathione Attenuates Carbon Tetrachloride-Induced Liver Injury by Modulating Oxidative Imbalance and Inflammation
Rosanna Di Paola, Sergio Modafferi, Rosalba Siracusa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4429-4429
Open Access | Times Cited: 24
Rosanna Di Paola, Sergio Modafferi, Rosalba Siracusa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4429-4429
Open Access | Times Cited: 24
Innate immunity and early liver inflammation
Jordi Yang Zhou
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Jordi Yang Zhou
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
A Treg-specific long noncoding RNA maintains immune-metabolic homeostasis in aging liver
Chenbo Ding, Zhibin Yu, Esen Sefik, et al.
Nature Aging (2023) Vol. 3, Iss. 7, pp. 813-828
Closed Access | Times Cited: 15
Chenbo Ding, Zhibin Yu, Esen Sefik, et al.
Nature Aging (2023) Vol. 3, Iss. 7, pp. 813-828
Closed Access | Times Cited: 15
FIB-4 and APRI scores for progressive liver fibrosis diagnosis in children with biliary atresia
Hongyu Lyu, Yongqin Ye, Bin Wang
Frontiers in Pediatrics (2024) Vol. 11
Open Access | Times Cited: 5
Hongyu Lyu, Yongqin Ye, Bin Wang
Frontiers in Pediatrics (2024) Vol. 11
Open Access | Times Cited: 5
Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity
Yijie Li, Brittney O. Baumert, Nikos Stratakis, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 4, pp. 332-345
Open Access | Times Cited: 5
Yijie Li, Brittney O. Baumert, Nikos Stratakis, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 4, pp. 332-345
Open Access | Times Cited: 5
Alcoholic liver fibrosis: detection and treatment
Gianni Testino, Silvia Leone, Sharmila Fagoonee, et al.
Minerva Medica (2018) Vol. 109, Iss. 6
Closed Access | Times Cited: 40
Gianni Testino, Silvia Leone, Sharmila Fagoonee, et al.
Minerva Medica (2018) Vol. 109, Iss. 6
Closed Access | Times Cited: 40
Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia
И. В. Маев, А А Самсонов, Liudmila K Palgova, et al.
BMJ Open Gastroenterology (2020) Vol. 7, Iss. 1, pp. e000368-e000368
Open Access | Times Cited: 39
И. В. Маев, А А Самсонов, Liudmila K Palgova, et al.
BMJ Open Gastroenterology (2020) Vol. 7, Iss. 1, pp. e000368-e000368
Open Access | Times Cited: 39
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis
Carlo Smirne, Cristina Rigamonti, Carla De Benedittis, et al.
Disease Markers (2019) Vol. 2019, pp. 1-15
Open Access | Times Cited: 37
Carlo Smirne, Cristina Rigamonti, Carla De Benedittis, et al.
Disease Markers (2019) Vol. 2019, pp. 1-15
Open Access | Times Cited: 37
Clinical importance of laboratory biomarkers in liver fibrosis
Valdas Banys, Goda Aleknavičiūtė-Valienė
Biochemia Medica (2022) Vol. 32, Iss. 3, pp. 346-356
Open Access | Times Cited: 20
Valdas Banys, Goda Aleknavičiūtė-Valienė
Biochemia Medica (2022) Vol. 32, Iss. 3, pp. 346-356
Open Access | Times Cited: 20
Celecoxib-Loaded Cubosomal Nanoparticles as a Therapeutic Approach for Staphylococcus aureus In Vivo Infection
Samar Zuhair Alshawwa, Thanaa A. El‐Masry, Mohamed Nasr, et al.
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2247-2247
Open Access | Times Cited: 12
Samar Zuhair Alshawwa, Thanaa A. El‐Masry, Mohamed Nasr, et al.
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2247-2247
Open Access | Times Cited: 12
Fucoxanthin Enhances the Antifibrotic Potential of Placenta-derived Mesenchymal Stem Cells in a CCl4-induced Mouse Model of Liver
Vasilii N. Slautin, Konstantin Konyshev, I. V. Gavrilov, et al.
Current Stem Cell Research & Therapy (2024) Vol. 19, Iss. 11, pp. 1484-1496
Closed Access | Times Cited: 4
Vasilii N. Slautin, Konstantin Konyshev, I. V. Gavrilov, et al.
Current Stem Cell Research & Therapy (2024) Vol. 19, Iss. 11, pp. 1484-1496
Closed Access | Times Cited: 4
CD4 T Cells Acquire Cytotoxic Properties to Modulate Cellular Senescence and Aging
Yehezqel Elyahu, Ilana Feygin, Noa Pinkas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Yehezqel Elyahu, Ilana Feygin, Noa Pinkas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
New Biomarkers in Liver Fibrosis: A Pass through the Quicksand?
Marzia Tagliaferro, Mariapaola Marino, Valerio Basile, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 8, pp. 798-798
Open Access | Times Cited: 4
Marzia Tagliaferro, Mariapaola Marino, Valerio Basile, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 8, pp. 798-798
Open Access | Times Cited: 4
Extracellular vesicles from mesenchymal stem cells improve liver injury in rats with mild liver damage. Underlying mechanisms and role of TGFβ
Gergana Mincheva, Victoria Moreno‐Manzano, Vicente Felipo, et al.
Life Sciences (2025) Vol. 364, pp. 123429-123429
Closed Access
Gergana Mincheva, Victoria Moreno‐Manzano, Vicente Felipo, et al.
Life Sciences (2025) Vol. 364, pp. 123429-123429
Closed Access
Diagnosis of liver disorder
Ramandeep Sandhu, Harpreet Kaur Channi, Deepika Ghai, et al.
Elsevier eBooks (2025), pp. 279-293
Closed Access
Ramandeep Sandhu, Harpreet Kaur Channi, Deepika Ghai, et al.
Elsevier eBooks (2025), pp. 279-293
Closed Access
